# Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases

> **NCT07485166** · — · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 810 (estimated)

## Conditions studied

- Advanced Non-squamous Non-small-cell Lung Cancer
- Advanced Squamous Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Initiation of nivolumab
- **DRUG:** Initiation of docetaxel

## Key facts

- **NCT ID:** NCT07485166
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-03-12
- **Primary completion:** 2026-09-12
- **Final completion:** 2027-03-12
- **Target enrollment:** 810 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- Food and Drug Administration (FDA)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07485166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07485166, "Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07485166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*